Business Description
Ananda Pharma PLC
ISIN : GB00BDQPXQ60
Share Class Description:
STU:1FX: Ordinary SharesTotal Employee Number:
9Compare
Compare
Traded in other countries / regions
1FX.GermanyANA.UK IPO Date
2022-06-03Description
Ananda Pharma PLC is a UK-based biopharmaceutical company developing regulatory-approved, cannabidiol medicines to treat complex, chronic conditions, including endometriosis (funded by NHS Scotland) and chemotherapy-induced peripheral neuropathy (funded by NIHR).
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.77 | |||||
Equity-to-Asset | 0.09 | |||||
Debt-to-Equity | 2.69 | |||||
Debt-to-EBITDA | -0.21 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -6.2 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
12-1 Month Momentum % | -75 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.25 | |||||
Quick Ratio | 0.25 | |||||
Cash Ratio | 0.22 | |||||
Days Sales Outstanding | 5913 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -81.3 | |||||
Shareholder Yield % | 16.98 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Operating Margin % | -87800 | |||||
Net Margin % | -90220 | |||||
EBITDA Margin % | -74300 | |||||
FCF Margin % | -16233.33 | |||||
OCF Margin % | -16233.33 | |||||
ROE % | -865.83 | |||||
ROA % | -122.11 | |||||
ROIC % | -107.41 | |||||
3-Year ROIIC % | -175.74 | |||||
ROC (Joel Greenblatt) % | -318.6 | |||||
ROCE % | -764.05 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -0.59 | |||||
EV-to-EBITDA | -0.69 | |||||
EV-to-Revenue | 509.65 | |||||
EV-to-FCF | -3.12 | |||||
Earnings Yield (Greenblatt) % | -169.27 | |||||
FCF Yield % | -34.5 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ananda Pharma PLC Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.006 | ||
| EPS (TTM) (€) | -0.002 | ||
| Beta | -0.9871 | ||
| 3-Year Sharpe Ratio | -0.16 | ||
| 3-Year Sortino Ratio | -0.33 | ||
| Volatility % | 69.04 | ||
| 14-Day RSI | - | ||
| 14-Day ATR (€) | 0.000014 | ||
| 20-Day SMA (€) | 0.0005 | ||
| 12-1 Month Momentum % | -75 | ||
| 52-Week Range (€) | 0.0005 - 0.002 | ||
| Shares Outstanding (Mil) | 4,299.15 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ananda Pharma PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ananda Pharma PLC Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Ananda Pharma PLC Frequently Asked Questions
What is Ananda Pharma PLC(STU:1FX)'s stock price today?
The current price of STU:1FX is €0.00. The 52 week high of STU:1FX is €0.00 and 52 week low is €0.00.
When is next earnings date of Ananda Pharma PLC(STU:1FX)?
The next earnings date of Ananda Pharma PLC(STU:1FX) is .
Does Ananda Pharma PLC(STU:1FX) pay dividends? If so, how much?
Ananda Pharma PLC(STU:1FX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Ananda Pharma PLC
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers